Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: A prospective, randomized study

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 3, 2013, Pages

  Janagond, A B ^a   Kanwar, A J ^a   Handa, S ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; EMOLLIENT AGENT; ETRETIN; FOLIC ACID; METHOTREXATE;

ANEMIA; ANOREXIA; ARTICLE; CHEILITIS; CLINICAL EVALUATION; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MUCOSAL DRYNESS; NAUSEA AND VOMITING; PRIORITY JOURNAL; PUSTULOSIS PALMOPLANTARIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT RESPONSE;

ACITRETIN; ADOLESCENT; ADULT; FOOT; HAND; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATOLYTIC AGENTS; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; PSORIASIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874114032     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12004     Document Type: Article

References (21)

1. Lomholt G,. Psoriasis: Prevalence, Spontaneous Cause and Genetics. GEC, Copenhagen, 1963.
2. Farber EM, Nall ML,. The natural history of psoriasis in 5,600 patients. Dermatologica 1974; 148: 1-18.
3. Kumar B, Saraswat A, Kaur I,. Palmoplantar lesions in psoriasis: a study of 3065 patients. Acta Derm Venereol 2002; 82: 192-195.
4. Guinot C, Latreille J, Perrussel M, Doss N, Dubertret L,. Psoriasis: characterization of six different clinical phenotypes. Exp Dermatol 2009; 18: 712-719.
5. Adişen E, Tekin O, Gülekon A, Gürer MA,. A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients. J Eur Acad Dermatol Venereol 2009; 23: 814-819.
6. Spuls PI, Hadi S, Rivera L, Lebwohl M,. Retrospective analysis of the treatment of psoriasis of the palms and soles. J Dermatolog Treat 2003; 14 (Suppl 2): 21-25.
7. Thiers BH,. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis. J Am Acad Dermatol 1997; 37 (3 Pt 2): S69-S71.
8. Rivard J, Janiga J, Lim HW,. Tacrolimus ointment 0.1% alone and in combination with medium-dose UVA1 in the treatment of palmar or plantar psoriasis. J Drugs Dermatol 2006; 5: 505-510.
9. Neumann NJ, Mahnke N, Korpusik D, Stege H, Ruzicka T,. Treatment of palmoplantar psoriasis with monochromatic excimer light (308-nm) versus cream PUVA. Acta Derm Venereol 2006; 86: 22-24.
10. Schroder K, Zaun H, Holzmann H, Altmeyer P, el-Gammal S,. Pustulosis palmo-plantaris: clinical and histological changes during etretin (acitretin) therapy. Acta Derm Venereol Suppl (Stockh) 1989; 146: 111-116.
11. Al-Mutairi N, Joshi A, Nour-Eldin O,. Punctate palmoplantar keratoderma (Buschke-Fischer-Brauer disease) with psoriasis: a rare association showing excellent response to acitretin. J Drugs Dermatol 2005; 4: 627-634.
12. Ettler K, Richards B,. Acitretin therapy for palmoplantar pustulosis combined with UVA and topical 8-MOP. Int J Dermatol 2001; 40: 541-542.
13. Guenther LC,. Alefacept is safe and efficacious in the treatment of palmar plantar pustulosis. J Cutan Med Surg 2007; 11: 202-205.
14. Jacobi A, Schuler G, Hertl M,. Differential clinical response to alefacept in combination with methotrexate in two patients with refractory palmar psoriasis. Br J Dermatol 2007; 156: 178-180.
15. Cohen DJ, Scherschun L,. Case reports: practical experience with efalizumab in hand and foot psoriasis. J Drugs Dermatol 2007; 6: 1224-1230.
16. Zip C,. Treatment of hand and foot psoriasis with emphasis on efalizumab. Skin Therapy Lett 2007; 12: 7-9.
17. Brunasso AMG, Salvini C, Massone C,. Efalizumab for severe palmo-plantar psoriasis: an open-label pilot trial in five patients. J Eur Acad Dermatol Venereol 2009; 23: 415-419.
18. Farley E, Masrour S, McKey J, Menter A,. Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool. J Am Acad Dermatol 2009; 60: 1024-1031.
19. Sezer E, Erbil AH, Kurumlu Z, Taştan HB, Etikan I,. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis. J Dermatol 2007; 34: 435-440.
20. Khandpur S, Sharma VK,. Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasis. Clin Exp Dermatol 2011; 36: 613-616.
21. Ortiz Z, Shea B, Saurez Almazor M, et al. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev 2000; 2: CD000951.